Codex @codex  0

An organising protein for Drosophila melanogaster germ plasm; ectopic local expression can redirect germ-cell formation in a permissive cellular context.

The outer mitochondrial membrane separates the surrounding cytosol from the intermembrane space. Channels permit passage of many small molecules, while the inner mitochondrial membrane supplies the main selective barrier between them and the mitochondrial matrix.^[ref]

Small-solute access does not imply unrestricted access for proteins. The cytochrome c addition in the isolated mitochondria respiration experiment tests a consequence of damage to this boundary. Organelle protein import describes purposeful delivery across mitochondrial boundaries.

Ovalbumin is a major protein of chicken egg white with a storage role. It is distinct from serum albumin despite the related names. Its solubility and abundance make it a convenient experimentally recognized protein, including the historical binding comparison discussed under Papain digestion of IgG. ^[ref]

A stress-responsive regulatory protein encoded by TP53. Different mutant alleles can alter tissue competition in different ways; a mutation is not an invariant measure of competitive fitness.

P. A. Janmey investigated how networks of cytoskeletal proteins bear mechanical loads. A 1991 study compared purified actin, tubulin and vimentin assemblies under deformation. The networks differed in stiffness and resistance to disruption, with vimentin networks especially able to withstand large deformations.^[ref]

The comparison separated the mechanical properties of a filament network from the complexity of an intact cell. A material's response to a small deformation does not completely predict whether it survives a large one. This connects cytoskeleton composition to the distinct questions of stiffness, viscoelasticity and mechanical resilience.

Study of ancient proteins, including sequence information used to test relationships of extinct organisms.

PALS1 is a scaffold protein in the Crumbs-associated polarity complex. It links membrane-associated polarity components with partners including PATJ, helping organize apical-junctional architecture in epithelial cells. As a scaffold, its influence depends on which partners are present and where the complex assembles. Loss of a localized assembly can therefore affect tissue organization without PALS1 itself being an enzyme. ^[ref]

A 1984 primary experiment localized IP3-evoked release using pancreatic acinar cells isolated from rat pancreas with collagenase. A homogenized preparation was separated by differential centrifugation, then by a sucrose step density gradient or precipitation with magnesium chloride. The readout was IP3-induced calcium release per mass of protein across fractions. Release tracked two endoplasmic reticulum markers, RNA content and an enzyme activity, across several separation methods. Marker activities for mitochondria and the cell membrane supplied contrasting comparisons: release correlated negatively with them.^[ref]

Agreement across distinct fractionations supports an endoplasmic reticulum-associated source in this preparation. “Nonmitochondrial” alone only excludes a candidate; positive compartment markers add localization evidence. Marker comparisons control the localization inference, rather than replacing a no-IP3 release comparison. Fractionation may mix or damage compartments, and correlation does not itself identify the IP3 receptor protein. This calcium release readout also does not directly measure secretion or establish identical responses in every biological cell.

In 1967, James D. Jamieson and George E. Palade incubated guinea pig pancreas slices, following a three-minute pulse of tritium-labeled leucine with excess unlabeled leucine. This pulse-chase analysis marked newly made proteins while reducing subsequent incorporation. Fixed, Epon-embedded thin sections were mounted on coated grids, covered with Ilford L-4 photographic emulsion, developed and stained for electron microscopy. Autoradiography located photographic grains relative to pancreatic acinar cell structures.^[ref]

Pulse-end samples provided a temporal reference: label lay mainly over rough endoplasmic reticulum; later samples shifted toward peripheral Golgi apparatus elements, condensing vacuoles and secretory granules. As a contamination check, isolated granule pellets were also examined by autoradiography: early pellet labeling chiefly marked condensing vacuoles. Grids from the compared pellet samples were coated together to control photographic processing. This supported transport of a previously labeled cohort rather than separate synthesis at each location. Fixed samples did not track individual proteins; localization was finite, and labeling was not absolutely exclusive to secretory cargo. The result concerns this preparation, not every protein in every biological cell.^[ref]

PAR-6 is a polarity scaffold protein that interacts with an atypical protein kinase C and the small GTPase Cdc42. These interactions connect a nucleotide-dependent signal to localized kinase activity and cortical organization. Family members and developmental contexts differ, so a general complex architecture does not establish an identical role in every tissue. Positioning the complex helps cells distinguish one surface domain from another. ^[ref]

A paratope is the recognizing surface on an antibody; the epitope is the recognized feature on its antigen. Contacts depend on spatial arrangement and chemistry, including hydrogen bonds and Van der Waals forces. Thus a paratope is not simply a slot for a protein primary structure string. A folded protein can bring distant amino acid residues into one epitope. ^[ref]

A crosslinking approach using photoactivatable nucleoside analogues to mark RNA–protein contacts. Characteristic sequence changes help localize contacts, connecting chemical labeling with transcriptome-wide binding maps.^[ref]

A guide specifies the target; the attached Cas9 machinery determines whether expression changes through DNA repair or direct transcriptional regulation. In CRISPR genome editing, a guide RNA supplies sequence complementarity to a genomic target adjacent to a suitable protospacer adjacent motif. The commonly used Cas9 from Streptococcus pyogenes recognizes an NGG motif, where N is any base. Recognition involves both that motif and pairing between the guide and target DNA; an arbitrary complementary sequence is therefore insufficient. In mammalian experiments, a nuclear-localized Cas9 and guide can be delivered by expression constructs or as a preassembled ribonucleoprotein. Multiplexing means supplying several guides, rather than engineering a new DNA-binding protein for every target. The original mammalian demonstration combined programmable targeting with endogenous repair to change genomic sequences.^[ref]

For a loss-of-function experiment, a cut in an early constitutive exon is repaired by non-homologous end joining and related end-joining pathways. Insertions or deletions can change the reading frame, introduce a premature stop, and trigger nonsense-mediated decay. Neither cleavage nor an insertion/deletion automatically proves a gene knockout: repair can preserve the reading frame, alternative splicing can bypass the exon, and a mammalian cell may retain an intact allele. Targeting a promoter or enhancer can instead alter the amount or cell specificity of expression. Two guides can delete a defined regulatory segment, but the resulting junction and possible larger rearrangements need verification. homology-directed repair with a donor can introduce an expression tag, repair a mutation, or replace a regulatory sequence; its efficiency depends on cell state and competing repair pathways. Changing the genomic coding sequence can change protein activity without changing transcript abundance, so these outcomes should be distinguished.

Expression can also be controlled without cleavage. Catalytically inactive dCas9 retains guide-directed binding. Positioning it at an appropriate regulatory region can obstruct transcription; recruiting a repressive domain such as KRAB strengthens CRISPR interference in mammalian cells. Fusing an activation domain, or recruiting several activators, gives CRISPR activation at an endogenous promoter. These approaches preserve the coding sequence and permit graded or inducible perturbation, although chromatin context and guide position strongly affect performance. Mammalian experiments comparing regulatory fusions established that the same targeting platform can repress or activate transcription.^[ref]

The readout should match the proposed mechanism: sequence the target for editing, measure messenger RNA by RT-qPCR, and measure the protein and its biological activity. Use multiple independent guides, a nontargeting guide, delivery-matched controls, and several independently derived clones or a controlled pooled experiment. Rescue with a guide-resistant functional gene supports causality; overexpression rescue alone can have dosage artefacts. Check relevant predicted off-target effects, assess cell viability, and distinguish direct expression changes from selection of surviving cell states. A nuclease perturbation can itself activate a DNA-damage response. Thus the strongest conclusion connects a verified molecular perturbation to RNA, protein and phenotype, rather than treating a guide-dependent phenotype as sufficient evidence.

PCR converts a selected DNA sequence into a detectable and manipulable quantity; different downstream measurements give it different uses. A pair of PCR primers defines the interval amplified by DNA polymerase. Repeated denaturation, annealing and extension produce approximately $N_n=N_0(1+E{)}^n$ copies while PCR efficiency $E$ remains constant. At ideal efficiency, twenty cycles give about a millionfold amplification; depletion and accumulating products eventually cause a PCR plateau. Specificity derives from both primer-binding sites and their orientation, and should be checked by product size, melting behaviour or sequencing.

One application is genotyping. A disease-associated substitution can be detected by amplifying the surrounding region and reading the sequence, probing with an allele-specific oligonucleotide, or digesting a restriction site changed by the variant. An early demonstration amplified the human beta-globin region for restriction-based diagnosis of sickle cell disease. Amplification increased sensitivity; the restriction pattern supplied the allele information.^[ref] A negative disease-specific signal is interpretable only if a control locus amplifies, because poor extraction or an inhibitor can mimic absence of an allele. In forensic DNA profiling, several short tandem repeat loci are amplified and fragment lengths compared. A multilocus match supports identity statistically; it does not eliminate contamination, mixtures, allelic dropout or the need for appropriate population-frequency estimates.

For infectious agents, primers can detect a pathogen-specific DNA sequence. An RNA virus first requires reverse transcription, followed by polymerase chain reaction. In RT-qPCR, fluorescence is monitored during amplification, and a threshold cycle is related to starting RNA using calibrated standards and efficiency measurements. This also measures changes in cellular gene expression: compare a target transcript between conditions after suitable normalization. Include extraction controls, a no-template reaction and, for RNA measurements, a no-reverse-transcriptase control to detect genomic DNA contamination. A positive pathogen signal establishes the presence of target nucleic acid, not necessarily a viable organism or infectious virus. Likewise, RNA abundance is not a direct measurement of protein abundance or transcription rate, since RNA degradation also matters.

PCR is also a preparative method. Amplified coding sequences can be assembled into expression vectors; primer tails can add restriction sites, assembly overlaps, sequencing adaptors or an affinity tag. High-fidelity polymerase reduces unwanted substitutions, but the final clone should still be sequenced. Site-directed mutagenesis introduces a specified substitution using mutagenic primers, whereas error-prone PCR creates a library for directed evolution. Sequencing after selection distinguishes the intended change from other mutations. In chromatin immunoprecipitation, quantitative amplification of recovered loci can test enrichment of a DNA-associated protein, with input DNA and immunoprecipitation controls needed to interpret it.

These examples separate presence, identity, quantity and construction. Endpoint band intensity is a poor substitute for quantitative amplification measured before the PCR plateau; multiplex assays can also suffer unequal amplification. The appropriate answer therefore identifies what is amplified, what is measured, and which alternative explanation each control excludes.

Strong lac expression requires relief of lactose-responsive repression together with a favourable glucose-responsive activation state. In Escherichia coli, the lac operon encodes beta-galactosidase, lactose permease and a transacetylase. LacI binds operator DNA and represses transcription; binding of the inducer allolactose shifts its conformation and reduces operator occupancy. Basal expression provides enough permease and beta-galactosidase to import and process some lactose, including formation of allolactose. This explains induction without requiring a completely silent system somehow to manufacture its own detector.

Glucose availability affects positive regulation. When glucose is scarce, the physiological state of the phosphotransferase system favours activation of adenylate cyclase and increased cyclic AMP. Binding of cyclic AMP activates catabolite activator protein, also called CRP, which binds near the lac promoter and helps recruit RNA polymerase. In glucose-rich conditions this activation is reduced. Operator repression and activator-dependent recruitment act at distinct sites, so relief of repression does not guarantee maximum expression. The promoter behaves approximately as a requirement for lactose availability AND glucose scarcity, but its quantitative output is graded rather than a perfect digital gate.

Glucose also regulates inducer entry. During glucose uptake through the phosphotransferase system, the glucose-specific EIIA glucose protein tends to be dephosphorylated. That form can bind and inhibit lactose permease, reducing lactose entry and hence allolactose formation. This inducer exclusion reinforces repression while a preferred substrate is being used. Mutations in the central cytoplasmic loop of the permease that abolish regulation and binding provide a way of separating transport inhibition from promoter regulation.^[ref] It is therefore incomplete to attribute every glucose effect to cyclic AMP alone.

The four limiting conditions make the integration clear. Without lactose, LacI represses whether glucose is high or low; an active CRP cannot simply substitute for inducer. With lactose and abundant glucose, induction is limited by weak activation and often by inducer exclusion. With lactose and little glucose, repression is relieved and CRP-dependent recruitment is favoured, giving the highest expression. With both sugars initially available, glucose consumption followed by adaptation to lactose can produce diauxic growth; the timing depends on concentrations, transport and culture conditions.

Genetic and physiological controls distinguish the mechanisms. A loss-of-function LacI mutation should remove inducer dependence and can be complemented by a functional repressor supplied in trans. An operator mutation acts primarily in cis, on the linked operon. A superrepressor that cannot respond appropriately to inducer can remain repressive despite lactose. Compare promoter reporters and lactose-uptake measurements separately, because an uptake defect and a transcription defect can give similar growth phenotypes. Adding cyclic AMP tests one activation arm, but cannot necessarily overcome a permease blocked by inducer exclusion. The cell combines a local substrate signal with a global carbon-use signal, acting through both transcription and transport.

Divergence preserves a structural framework while function changes; convergence produces similar solutions within otherwise different frameworks. Evidence should compare the entire protein fold, the sequence order and connectivity of structural elements, and the geometry of functional residues. Similar activity alone cannot distinguish either history, because many unrelated structures can perform the same reaction.

The globin fold illustrates divergence. myoglobin and the alpha and beta chains of haemoglobin share a predominantly alpha-helical architecture and a homologous pocket for haem. The proximal histidine coordinates the iron, and the surrounding pocket modulates ligand binding. Myoglobin is principally a monomeric oxygen-binding protein, whereas haemoglobin subunits interact within a tetramer to give cooperative oxygen transport. Their conserved core architecture and alignable sequence positions support descent from an ancestral globin, with duplication and subsequent specialization. Structural similarity remains recognizable even when many surface residues have changed. The functional difference arises partly from new intersubunit interactions rather than construction of an entirely new oxygen-binding chemistry.

Trypsin, chymotrypsin and elastase provide a second divergent series. They retain the chymotrypsin-like fold and corresponding catalytic triad residues, but changes in the specificity pocket favour different side chains next to the scissile peptide bond. A negatively charged pocket in trypsin favours basic residues; a hydrophobic pocket in chymotrypsin favours bulky aromatic residues; obstruction of the pocket in elastase favours smaller side chains. Conserved topology, residue correspondence and related sequences support common ancestry. The particular numbering of homologous catalytic residues is useful shorthand, but matching residue numbers alone is not evolutionary evidence.

For convergence, compare chymotrypsin-like proteases with subtilisin. Both are serine proteases using a serine nucleophile, histidine as a proton-transfer partner and an aspartate that organizes the histidine. Both stabilize a tetrahedral intermediate and form an acyl-enzyme. Nevertheless, their global folds differ, and the catalytic residues occur in different orders along the polypeptide: His–Asp–Ser in the chymotrypsin family and Asp–His–Ser in subtilisin. The similar local catalytic arrangement embedded in distinct topologies is evidence for independent assembly of effective serine-protease chemistry. Early three-dimensional structures made comparison of these spatial arrangements possible.^[ref]

The contrast is between a conserved scaffold with modified chemistry or specificity and independently organized scaffolds converging on a favourable active-site geometry. Chemical constraints help explain convergence: catalysis benefits from appropriately positioned acids, bases, nucleophiles and stabilizing charges. They do not require the rest of the protein to become similar.

Structural inference has limits. A common small motif can occur by chance or reflect physical constraints; failure to detect sequence similarity does not prove absence of ancient homology. Strong conclusions combine global structural alignment, sequence-profile comparisons, taxonomic distribution and molecular phylogeny. Domain duplication, rearrangement and loss can complicate a simple family tree. Thus structural resemblance is most persuasive when its extent and topology are evaluated alongside independent evolutionary evidence, rather than classifying every shared helix or catalytic residue as proof of common descent.

Selecting tight binding to a transition-state analogue is an ingenious route to catalytic activity, but it is an indirect and incomplete selection for a useful enzyme. A catalytic antibody can be raised against a stable molecule designed to resemble a reaction's transition state. Preferential stabilization of that configuration relative to the substrate can lower the activation free energy. In an early demonstration, antibodies elicited against suitable haptens catalysed ester hydrolysis and were inhibited by the corresponding transition-state analogues.^[ref] This established a principle of molecular recognition, rather than a guarantee that any tightly bound hapten yields efficient catalysis.

A stable analogue necessarily differs from the actual fleeting transition state. Antibody maturation selects affinity for the immunizing molecule, including groups used to attach it to a carrier, rather than directly selecting rapid repeated turnover of the desired substrate. A useful catalyst must position acid/base groups, exclude or organize water, control electrostatics, traverse all reaction intermediates and release products. Binding one geometrical approximation need not optimize those steps. Strong product binding can inhibit turnover; excellent affinity can coexist with a small turnover number. A large rate enhancement over an exceptionally slow uncatalysed reaction can still give an impractically slow absolute reaction. Limited substrate scope, difficult analogue synthesis and the production or stability requirements of an antibody scaffold add practical costs.

Performance must therefore be measured as product formation over multiple turnovers, with purified protein, no-antibody and unrelated-antibody controls, and suitable checks against contaminating enzymes. Report both turnover and substrate dependence, preferably catalytic efficiency, alongside stereoselectivity, stability and achievable substrate loading. Competitive inhibition by the immunizing hapten supports involvement of the binding site, but cannot by itself exclude every alternative source of activity.

Directed evolution instead mutates a gene, expresses a library and screens or selects the actual property required. Repeated selection of subtilisin E variants for activity in an organic solvent demonstrated improvement under the intended reaction conditions without requiring a complete mechanistic prediction of every mutation.^[ref] Starting from a natural enzyme supplies a scaffold already capable of catalytic turnover. The assay can jointly select activity, selectivity or stability, although improvements are only as relevant as the assay: better expression must not be mistaken for a better purified catalyst.

Contemporary computational enzyme design can place a modelled catalytic arrangement into a protein scaffold, then use experimental screening and directed evolution to improve it. Designed Kemp eliminases illustrate the combination of mechanistic design with subsequent empirical optimization.^[ref] Rational mutagenesis and recombination can likewise focus a library on useful positions. These methods still face imperfect models and finite search capacity; they succeed by testing catalysis more directly and iterating. The question's historical premise is best read as a loss of prominence of the classical hapten-immunization strategy, rather than proof that catalytic-antibody research has universally ceased. The decisive advance is selection for the reaction and operating conditions, with binding treated as one component of performance.

Location determines access to substrates, cofactors and transport routes; identical catalytic potential can therefore serve different physiological functions in different compartments. In carbohydrate metabolism, the plasma membrane, mitochondrion and endoplasmic reticulum are selective barriers, not merely containers. A soluble enzyme cannot use a metabolite efficiently if that metabolite cannot reach its compartment, while transporter abundance matters chiefly when the transporter is in the appropriate membrane.

Most glycolysis occurs in the cytosol, whereas pyruvate dehydrogenase complex and much oxidative metabolism occur in the mitochondrial matrix. Pyruvate entry therefore links cytosolic glucose breakdown to mitochondrial oxidation. Cytosolic NADH does not freely cross the inner mitochondrial membrane: the malate-aspartate shuttle and glycerol phosphate shuttle transfer reducing equivalents through different routes. Their operation affects the energetic outcome of glucose use. In gluconeogenesis, mitochondrial pyruvate carboxylase produces oxaloacetate, but oxaloacetate itself does not freely cross that membrane. Conversion into transportable intermediates, or formation of phosphoenolpyruvate in the appropriate compartment, allows carbon to reach cytosolic steps. Enzyme localization thus imposes an obligatory transport and redox problem, not just an extra reaction label.

At the final step of hepatic glucose production, the catalytic site of glucose-6-phosphatase faces the endoplasmic-reticulum lumen. Glucose-6-phosphate must reach it through the associated transport system. Hydrolysis makes free glucose available for export, whereas the phosphate ester is largely retained by membranes. Muscle can mobilize cytosolic glycogen to glucose-6-phosphate for its own glycolysis, but lacks the hepatic glucose-6-phosphatase system needed for substantial release of that carbon as free blood glucose. Tissue function therefore depends on both enzyme expression and the membrane machinery surrounding the enzyme.

Transporter traffic changes function without waiting for new protein synthesis. In resting muscle and adipose cells, much GLUT4 resides in intracellular vesicles. Insulin signalling promotes its delivery to the cell surface and increases glucose uptake; internalization subsequently reduces surface transport capacity. Classical membrane-fractionation and transport-site measurements supported redistribution from an intracellular pool to the plasma membrane.^[ref] Fractionation requires compartment markers, and surface labelling or microscopy provides an independent check: altered fraction recovery alone could otherwise mimic redistribution. Total cellular GLUT4 is not an adequate proxy for surface uptake capacity.

Polarity provides another example. In intestinal epithelial cells, apical SGLT1 uses the sodium electrochemical gradient to take up glucose, whereas basolateral GLUT2 enables exit towards the circulation. Basolateral sodium-potassium ATPase maintains the sodium gradient. Misplacing a transporter can disrupt vectorial absorption despite normal intrinsic transport activity. Glycogen-associated regulatory enzymes similarly gain access to a localized substrate pool. These examples show why localization should be tested with activity and transport measurements as well as images. Compartmentation creates direction, regulation and tissue specialization, while requiring transporters that connect the separated reactions.

A signalling pathway can be changed at its receptor, nucleotide switch, kinase or messenger-removal step; the phenotype depends on the exact molecular intervention. A useful comparison follows the perturbation through a measured biochemical intermediate to the cellular response, rather than simply listing drugs and pathogens.

imatinib inhibits the deregulated BCR-ABL tyrosine kinase responsible for a major proliferative signal in chronic myeloid leukaemia. Occupancy of its kinase ATP-binding region favours an inactive configuration and reduces substrate phosphorylation and downstream survival signalling. Early cellular experiments compared BCR-ABL-expressing cells with cells lacking that driver and measured growth and phosphorylation, showing the value of a molecularly defined target.^[ref] Inhibition need not mean complete specificity: related kinases can also be affected, and target-site mutations or alternative survival pathways can confer resistance. A resistant target mutant, where experimentally justified, is a stronger mechanistic control than growth inhibition alone.

At a cell-surface receptor, a beta-adrenoceptor antagonist reduces catecholamine activation of a G protein-coupled receptor and hence its downstream response. In contrast, inhibiting a phosphodiesterase can prolong a cyclic-nucleotide signal after it has been generated. These interventions illustrate why a lower response may result from reduced production, whereas a prolonged response can arise from reduced removal. Binding measurements, second-messenger time courses and downstream phosphorylation distinguish the two.

cholera toxin hijacks a nucleotide switch rather than competing with extracellular ligand. Its binding component recognizes a cell-surface glycolipid, enabling uptake and delivery of the catalytic component. The toxin transfers ADP-ribose from NAD to the stimulatory G-protein alpha subunit, impairing GTPase-mediated shutoff. Persistent stimulation of adenylyl cyclase increases cyclic AMP and protein kinase A activity. In intestinal epithelium, increased CFTR-dependent chloride secretion promotes salt and water loss. Early experiments linked toxin-dependent modification of a membrane GTP-binding protein to increased adenylate-cyclase activity; the later intestinal pathway supplies the physiological interpretation.^[ref]

pertussis toxin also catalyses ADP-ribosylation, but acts on inhibitory Gi/o-family alpha subunits and prevents normal receptor coupling. It therefore favours the inactive, GDP-bound state of those switches and removes receptor-mediated inhibitory control in pathways where Gi suppresses adenylate cyclase. It must not be described as simply locking every G protein in its active state: the two toxins can increase cyclic AMP through different molecular routes. Gi/o also regulates effectors other than adenylate cyclase, making the outcome cell dependent.

Controls should include inactive toxin or catalytic mutants, uninfected cells, receptor and target expression, and direct messenger or substrate-phosphorylation measurements. Intracellular delivery requirements matter: failure of an extracellular catalytic fragment to act need not disprove its enzyme activity. Rescue downstream of a blocked step can map pathway order, but should be interpreted alongside possible parallel effects. Drugs and bacterial effectors can both reveal signalling architecture, provided their biochemical target is separated from the final phenotype.

Selective destruction makes key transitions depend on rebuilding proteins, rather than merely reversing their phosphorylation state. ubiquitin-proteasome system supplies this directionality while cyclin-dependent kinases and phosphatases provide more rapidly reversible regulation. An ubiquitin-activating enzyme uses ATP to activate ubiquitin; transfer through an ubiquitin-conjugating enzyme and recognition by an ubiquitin ligase directs substrate modification. Suitable polyubiquitin chains target proteins to the proteasome for unfolding and destruction. Substrate recognition, rather than a general increase in protein breakdown, gives temporal specificity.

At the G1/S transition, an SCF ubiquitin ligase can recognize a phosphorylated inhibitor of a cyclin-dependent kinase. In budding yeast, multisite phosphorylation of Sic1 promotes its destruction, releasing S-phase kinase activity. This links a threshold of previous kinase activity to removal of an inhibitor. Different SCF substrate receptors recognize different proteins, and phosphorylation-dependent recognition is important for many, but not every, SCF target. Destruction reinforces entry into the new state while the kinase network supplies additional feedback.

The anaphase-promoting complex controls a particularly decisive transition. Its Cdc20-associated form is restrained by the spindle checkpoint until chromosome attachment conditions permit progression. Ubiquitination and destruction of securin release separase, which cleaves the cohesin component that holds sister chromatids together. Chromatid separation cannot be undone by putting the phosphate groups back onto an intact securin molecule, because that molecule has been degraded and the cohesion linkage has been cleaved. The combination of selective proteolysis and substrate cleavage explains why a brief regulatory transition commits the cell to anaphase.

Destruction of cyclin B lowers CDK1 activity and enables mitotic exit. Nondegradable cyclin blocked inactivation of maturation-promoting activity and exit from mitosis in frog experimental systems, directly testing necessity of cyclin destruction rather than merely observing a correlation.^[ref] The Cdh1-associated anaphase-promoting complex helps keep mitotic cyclins low through late mitosis and G1, creating an interval suitable for replication licensing. In animal cells, destruction of geminin also permits Cdt1 to support licensing. Subsequent kinase activation and licensing-factor regulation help prevent rereplication before the next cycle.

The mechanism is irreversible on the timescale of the transition, not an assertion that the cell can never make cyclin or securin again. ATP-dependent ubiquitin activation and proteasomal processing occur in an open, energy-consuming system; fresh gene expression later restores substrates under a different regulatory state. Conversely, ubiquitination alone is not synonymous with degradation: chain type and context can give other signals. Tests should compare normal and degron-mutant substrates at similar expression levels, monitor actual protein loss and kinase activity, and distinguish checkpoint arrest from failure of destruction itself. Proteolysis commits the cell by removing selected regulators, while checkpoint and feedback circuits determine when that commitment occurs.